PPARGC1A and Hepatic fibrosis: They share common acetylated protein substrates including FoxO3a, NF-κB, and PGC-1α for reducing inflammation and improving mitochondrial dysfunction as well as being involved in the AMPK pathway for reducing liver fibrosis [39,40].